In animal models, THR-184 provided nephroprotection from Ischemic Reperfusion Injury and Cisplatin-induced AKI by preventing renal tubular damage, inhibiting tubular apoptosis, and decreasing urinary NGAL (Carlson, 2018). This evidence concerns the gene LCN2 and acute kidney injury.